Invasive pneumococcal disease unmasks monoclonal immunoglobulins and antibody deficiencies: a multicenter prospective study in adults.
Serious pneumococcal infections reveal hidden blood cancers and immune defects, suggesting this infection should trigger screening for early disease detection.
This multicenter prospective Swedish study found that invasive pneumococcal disease in adults reveals previously undiagnosed monoclonal immunoglobulins and antibody deficiencies at rates higher than the general population, establishing IPD as a clinical trigger for plasma cell dyscrasia and humoral immune deficiency screening. The findings support an opportunistic, cost-effective screening strategy for early MGUS and myeloma detection in a high-risk clinical presentation.
What the study was
- Study design
- Multicenter prospective study
- Population
- Adults hospitalized with invasive pneumococcal disease at multiple Swedish centers
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Scientific reports
Why it surfaced
Multicenter prospective study demonstrating IPD as opportunistic trigger for MGUS/antibody deficiency screening. Clinically actionable: adds opportunistic early plasma cell dyscrasia detection opportunity. Sci Rep (Skovbjerg S, Gothenburg).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.